Literature DB >> 23812586

Structural basis for the inhibition of bacterial multidrug exporters.

Ryosuke Nakashima1, Keisuke Sakurai, Seiji Yamasaki, Katsuhiko Hayashi, Chikahiro Nagata, Kazuki Hoshino, Yoshikuni Onodera, Kunihiko Nishino, Akihito Yamaguchi.   

Abstract

The multidrug efflux transporter AcrB and its homologues are important in the multidrug resistance of Gram-negative pathogens. However, despite efforts to develop efflux inhibitors, clinically useful inhibitors are not available at present. Pyridopyrimidine derivatives are AcrB- and MexB-specific inhibitors that do not inhibit MexY; MexB and MexY are principal multidrug exporters in Pseudomonas aeruginosa. We have previously determined the crystal structure of AcrB in the absence and presence of antibiotics. Drugs were shown to be exported by a functionally rotating mechanism through tandem proximal and distal multisite drug-binding pockets. Here we describe the first inhibitor-bound structures of AcrB and MexB, in which these proteins are bound by a pyridopyrimidine derivative. The pyridopyrimidine derivative binds tightly to a narrow pit composed of a phenylalanine cluster located in the distal pocket and sterically hinders the functional rotation. This pit is a hydrophobic trap that branches off from the substrate-translocation channel. Phe 178 is located at the edge of this trap in AcrB and MexB and contributes to the tight binding of the inhibitor molecule through a π-π interaction with the pyridopyrimidine ring. The voluminous side chain of Trp 177 located at the corresponding position in MexY prevents inhibitor binding. The structure of the hydrophobic trap described in this study will contribute to the development of universal inhibitors of MexB and MexY in P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812586     DOI: 10.1038/nature12300

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  32 in total

1.  Crystal structure of bacterial multidrug efflux transporter AcrB.

Authors:  Satoshi Murakami; Ryosuke Nakashima; Eiki Yamashita; Akihito Yamaguchi
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

2.  MexAB-OprM-specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: discovery and early strategies for lead optimization.

Authors:  Kiyoshi Nakayama; Yohei Ishida; Masami Ohtsuka; Haruko Kawato; Ken ichi Yoshida; Yoshihiro Yokomizo; Shigeru Hosono; Toshiharu Ohta; Kazuki Hoshino; Hiroko Ishida; Kumi Yoshida; Thomas E Renau; Roger Léger; Jason Z Zhang; Ving J Lee; William J Watkins
Journal:  Bioorg Med Chem Lett       Date:  2003-12-01       Impact factor: 2.823

3.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex.

Authors:  Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

Review 4.  Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

Authors:  Olga Lomovskaya; Keith A Bostian
Journal:  Biochem Pharmacol       Date:  2006-01-19       Impact factor: 5.858

5.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

6.  Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Patrice Nordmann; Farid El Garch; Ludovic Cabanne; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

Authors:  Edward W Yu; Julio R Aires; Gerry McDermott; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

9.  Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa.

Authors:  Vladislav V Mokhonov; Ekaterina I Mokhonova; Hiroyuki Akama; Taiji Nakae
Journal:  Biochem Biophys Res Commun       Date:  2004-09-17       Impact factor: 3.575

10.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

View more
  96 in total

Review 1.  Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.

Authors:  Stephanie M Reeve; Michael N Lombardo; Amy C Anderson
Journal:  Future Microbiol       Date:  2015-10-30       Impact factor: 3.165

2.  The Structure and Interactions of Periplasmic Domains of Crucial MmpL Membrane Proteins from Mycobacterium tuberculosis.

Authors:  Nicholas Chim; Rodrigo Torres; Yuqi Liu; Joe Capri; Gaëlle Batot; Julian P Whitelegge; Celia W Goulding
Journal:  Chem Biol       Date:  2015-08-13

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.

Authors:  Son T Nguyen; Steven M Kwasny; Xiaoyuan Ding; Steven C Cardinale; Courtney T McCarthy; Hong-Suk Kim; Hiroshi Nikaido; Norton P Peet; John D Williams; Terry L Bowlin; Timothy J Opperman
Journal:  Bioorg Med Chem       Date:  2015-03-13       Impact factor: 3.641

5.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.

Authors:  Helen I Zgurskaya; Cesar A Löpez; S Gnanakaran
Journal:  ACS Infect Dis       Date:  2015       Impact factor: 5.084

Review 6.  Protein modeling: what happened to the "protein structure gap"?

Authors:  Torsten Schwede
Journal:  Structure       Date:  2013-09-03       Impact factor: 5.006

7.  Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.

Authors:  Leonie Greipel; Sebastian Fischer; Jens Klockgether; Marie Dorda; Samira Mielke; Lutz Wiehlmann; Nina Cramer; Burkhard Tümmler
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosis.

Authors:  Marie H Foss; Sovitj Pou; Patrick M Davidson; Jennifer L Dunaj; Rolf W Winter; Sovijja Pou; Meredith H Licon; Julia K Doh; Yuexin Li; Jane X Kelly; Rozalia A Dodean; Dennis R Koop; Michael K Riscoe; Georgiana E Purdy
Journal:  ACS Infect Dis       Date:  2016-05-13       Impact factor: 5.084

9.  Constant pH Molecular Dynamics Reveals How Proton Release Drives the Conformational Transition of a Transmembrane Efflux Pump.

Authors:  Zhi Yue; Wei Chen; Helen I Zgurskaya; Jana Shen
Journal:  J Chem Theory Comput       Date:  2017-11-20       Impact factor: 6.006

10.  Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.

Authors:  Hanno Sjuts; Attilio V Vargiu; Steven M Kwasny; Son T Nguyen; Hong-Suk Kim; Xiaoyuan Ding; Alina R Ornik; Paolo Ruggerone; Terry L Bowlin; Hiroshi Nikaido; Klaas M Pos; Timothy J Opperman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.